Clinical Trial Update: Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate Cancer [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluating soy protein to prevent recurrence after surgery in stage II prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Soy protein (soy protein)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Prostate Cancer | Phase 2, Phase 3 | Status: COMPLETED